The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127026231 12702623 1 I 20091013 20091014 20160831 20160831 EXP US-PFIZER INC-2009283280 PFIZER 63.00 YR M Y 82.54000 KG 20160831 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127026231 12702623 1 PS IBUPROFEN. IBUPROFEN 1 Oral UNK Y 18989 TABLET
127026231 12702623 2 SS IBUPROFEN. IBUPROFEN 1 Y 18989 TABLET
127026231 12702623 3 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 40 MG, UNK 0 40 MG
127026231 12702623 4 C ISOSORBIDE. ISOSORBIDE 1 Oral 20 MG, 1X/DAY 0 20 MG QD
127026231 12702623 5 C LASIX FUROSEMIDE 1 Oral 20 MG, AS NEEDED 0 20 MG
127026231 12702623 6 C LIPITOR ATORVASTATIN CALCIUM 1 Oral 40 MG, 1X/DAY 0 40 MG QD
127026231 12702623 7 C TIAZAC DILTIAZEM HYDROCHLORIDE 1 Oral 240 MG, 1X/DAY 0 240 MG QD
127026231 12702623 8 C MULTIVITAMINS VITAMINS 1 Oral 1 DF, 1X/DAY 0 1 DF TABLET QD
127026231 12702623 9 C OSCAL CALCIUM CARBONATE 1 Oral 500 MG, 2X/DAY 0 500 MG BID
127026231 12702623 10 C VITAMIN B12 + FOLIC ACID 2 Oral 1 MG, 1X/DAY 0 1 MG QD
127026231 12702623 11 C METHOTREXATE. METHOTREXATE 1 Subcutaneous 17.5 MG, WEEKLY 0 17.5 MG /wk
127026231 12702623 12 C FOSAMAX ALENDRONATE SODIUM 1 Oral 35 MG, WEEKLY 0 35 MG /wk
127026231 12702623 13 C MECLIZINE MECLIZINE HYDROCHLORIDE 1 Oral 25 MG, AS NEEDED 0 25 MG
127026231 12702623 14 C PREDNISON PREDNISONE 1 Oral 5 MG, 1X/DAY 0 5 MG QD
127026231 12702623 15 C PREDNISON PREDNISONE 1 Oral 2 MG, 1X/DAY AT BEDTIME 0 2 MG QD
127026231 12702623 16 C KCL POTASSIUM CHLORIDE 1 Oral 8 MEQ, 1X/DAY 0 8 MEQ QD
127026231 12702623 17 C ETANERCEPT ETANERCEPT 1 Subcutaneous 50 MG, WEEKLY 0 50 MG /wk
127026231 12702623 18 C FOLIC ACID. FOLIC ACID 1 Oral 1 MG, UNK 0 1 MG
127026231 12702623 19 C DILTIAZEM. DILTIAZEM 1 Oral 240 MG, UNK 0 240 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127026231 12702623 1 Osteoarthritis
127026231 12702623 2 Rheumatoid arthritis

Outcome of event

Event ID CASEID OUTC COD
127026231 12702623 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127026231 12702623 Chest pain

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127026231 12702623 1 20070524 20091012 0
127026231 12702623 3 20070523 0
127026231 12702623 4 1995 0
127026231 12702623 5 1995 0
127026231 12702623 6 1998 0
127026231 12702623 7 1995 0
127026231 12702623 8 1980 0
127026231 12702623 9 20051122 0
127026231 12702623 10 20070124 0
127026231 12702623 11 20070124 0
127026231 12702623 12 20051122 0
127026231 12702623 13 1995 0
127026231 12702623 14 20070831 0
127026231 12702623 15 20090519 0
127026231 12702623 16 20090812 0
127026231 12702623 17 20051227 0
127026231 12702623 18 20051122 0
127026231 12702623 19 1995 0